CTR Exam Prep [Data Collection] Questions and Answers Rated A

CTR Exam Prep [Data Collection] Questions and Answers Rated A What includes casefinding, abstracting, coding, f/u survivorship and outcomes? Data Collection system for locating every patient who is dx'd and/or tx'd w/ a reportable cancer at a facility. casefinding Two types of casefinding methods? Active and Passive Casefinding method that requires registry personnel retrieving source documents like path, rad, onc reports and considered more thorough and accurate. Active casefinding Casefinding method that comes from other depts notifying the registrar of potential reportable cases Passive casefinding QC procedure to monitor number of cases found Completeness logs A record that contains information about each patient from the time of dx and continuing throughout his or her life. Abstract. American college of surgeons commission on cancer COC if the facility is COC accredited the registry must submit to NCDB and their state registry National cancer data base NCDB Seer registries submit to National cancer institute: Surveillance epidemiology and end results State registries cannot submit to NCDB Has business agreements with hospital registries NCDB Abstracting manuals are used for standardization of data across all registries reapperance of dz that was thought to be cured or inactive (remission) recurrence starts from cells that were not removed or destroyed by original therapy recurrence starts from same cancer, came back in same site, regional nodes or distant site recurrence cancer arising from cells that have nothing to do with the earlier first cancer New occurrence Most important items a registrar must determine primary site and morphological type of tumor 5 parts of ICD 0 introduction and instructions. topography numeric list. morphology numeric list. alphabetic index including all site & histo terms. lists of synonyms and other changes. site code, four character for body site where tumor arose c50.8 topography six digit code: 4 digits: what tumor is specific histo. 5th digit=behavior. 6th digit=grade/agression morphology measures how much the malignant cell resembles a normal cell. less the diff=less malig cell looks like nml differentiation/grade all cases are coded and stored by primary site provides ongoing surveillance to determine if tx worked follow up purpose to assure continued medical surveillance and to allow meaningful end results reporting follow up f/u provides outcome or survival info common objectives of f/u determine pt's current vital status, pts medical status, collect info on any recurrence incld tx & any new primary ca. encourage pt to remain under continued medical surveillance f/u performed annually based on last date of contact 2 methods of f/u active and passive direct contact w/MD's, pt's or letters to other facilities Active follow up No pt or MD contact: hospital readmission or out pt visit or other outside resources-registry not sending out direct request passive follow up Analytic pt's dx'd w/i last 5 years or from registry reference date (which ever is shorter) according to the COC standards get 90% follow up rate All analytic cases from reference date according to the COC standards get 80% follow up rate If last date of contact exceeds 15 months they should be considered delinquent and remain in f/u until current info is obtained Follow up data includes Dates and types of treatment, site of distant mets, site and histo of subsequent primaries, date of last contact and status of patient and cancer reported to NCDB all updated follow up information moment of diagnosis throughout lifetime survivor Tool that informs patient of follow up medical care, physical and emotional challenges, changes in family and social relationships & issues in the workplace survivorship plan Three distinct phases of cancer survivorship Living with cancer. Living through cancer. Living beyond cancer Dx'd and having treatment. Undergoing treatment. Access to service to help cope with emotional, psychological and financial concers Living with cancer immediate time following treatment when risk of recurrence is high. Pt's are relieved that tx is finished, but big adjustment to no longer seeing md' on regular bases Living through cancer refers to being past tx and long term survivorship. Some pt's life returns to nml or "new" nml where life is similar to what it was before dx. some patients have long term physical problems or psychosocial problems or even severwe financial consequences due to the expense of cancer care Living beyond cancer Includes not only survival rates for cancer but also reponse to tx, time to first recurrence and other milestones outcomes measures the success and failures of cancer dx and tx outcomes